Grifols board secretary Nuria Martin Barnes said, “Based on the misinterpretation generated after the publication of Grifols’ response to the CNMV requirements, we would like to clarify that all of Grifols’ liabilities have already been included and disclosed in the audited financial statements published on March 8th, 2024, and confirmed by the regulator. The EUR1.1B is not a financial debt as it is related to the future rentals of the properties of more than 390 plasma donation centers worldwide and, therefore, does not represent any new debt.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
- Grifols says CNMV validates financial statements, indebtedness of Grifols
- Grifols sees addressing 2025 maturities ‘efficiently’ in first half of 2024
- Largest borrow rate increases among liquid names
- Grifols downgraded to Sell at Deutsche Bank on ‘problem’ of cash flow guidance
